2019
Dear Shareholders,
the Annual General Shareholders’ Meeting of Epigenomics AG has taken place on May 15, 2019 in Berlin. The presence amounted to around 25 % of the share capital. Shareholders approved all amended agenda items according to the Board’s proposal.
| Voting results (only in German) | |
| Resolution passed on aganda items 7, 9 and 10 (only in German) |
| Invitation to the Annual General Shareholders’ Meeting 2019 of Epigenomics AG | |
| Curriculum vitae of Mr Franz Thomas Walt | |
| Reports of the Executive Board on agenda items 6,7, 9 und 10 | |
| Annual Report 2018 (incl. Consolidated Financial Statements, Group Management Report, Supervisory Board Report, Key features of the internal control and risk management system and Remuneration Report) |
|
| Financial Statements 2018 (German HGB) incl. Key features of the internal control and risk management system (German version) |
|
| Explanatory Report by the Management Board on Disclosures Pusuant to Section 289a (1), Section 315a (1) HGB (German Version) | |
| Information on data protection | |
| Access to the Investor Portal of Epigenomics AG | Link |
Corporate Governance/Declaration of Governance
| 2018 | |
| Declaration of Compliance with the German Corporate Governance Code pursuant to Section 161 of the German Stock Corporation Act (AktG) | |
| Declaration of Governance and reporting on Corporate Governance pursuant to Section 289a German Commercial Code (HGB) |
Further information
| Explanation of Shareholders’ rights | |
| Articles of Association |
Counterproposals
| Counterproposal regarding agenda items 4, 5, 6, 7, 9 and 10 (only in German) | |
| Statement by the Supervisory Board regarding the counter-motions of DELPHI Unternehmensberatung AG on agenda items 4 and 5 |